These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22535279)

  • 1. Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.
    de Vries HS; de Heij T; Roelofs HM; te Morsche RH; Peters WH; de Jong DJ
    Dig Dis Sci; 2012 Jun; 57(6):1604-8. PubMed ID: 22535279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
    de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
    J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
    van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
    J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of azathioprine, 6-mercaptopurine, and 6-thioguanine on canine primary hepatocytes.
    LaDuke KE; Ehling S; Cullen JM; Bäumer W
    Am J Vet Res; 2015 Jul; 76(7):649-55. PubMed ID: 26111096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease.
    Duijvestein M; Molendijk I; Roelofs H; Vos AC; Verhaar AP; Reinders ME; Fibbe WE; Verspaget HW; van den Brink GR; Wildenberg ME; Hommes DW
    Cytotherapy; 2011 Oct; 13(9):1066-73. PubMed ID: 21846292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.
    Dulai PS; Siegel CA; Colombel JF; Sandborn WJ; Peyrin-Biroulet L
    Gut; 2014 Dec; 63(12):1843-53. PubMed ID: 24970900
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.
    Petit E; Langouet S; Akhdar H; Nicolas-Nicolaz C; Guillouzo A; Morel F
    Toxicol In Vitro; 2008 Apr; 22(3):632-42. PubMed ID: 18222062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease.
    Achkar JP; Stevens T; Easley K; Brzezinski A; Seidner D; Lashner B
    Inflamm Bowel Dis; 2004 Jul; 10(4):339-45. PubMed ID: 15475740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.
    Mantzaris GJ
    Curr Treat Options Gastroenterol; 2017 Mar; 15(1):84-104. PubMed ID: 28160250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.
    Yarur AJ; Kubiliun MJ; Czul F; Sussman DA; Quintero MA; Jain A; Drake KA; Hauenstein SI; Lockton S; Deshpande AR; Barkin JS; Singh S; Abreu MT
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1118-24.e3. PubMed ID: 25562796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
    Hagihara Y; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Crohns Colitis; 2014 Mar; 8(3):223-33. PubMed ID: 24011513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.
    Nielsen OH; Vainer B; Rask-Madsen J
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1699-708. PubMed ID: 11683683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations in the treatment of inflammatory bowel disease.
    Schwab M; Klotz U
    Clin Pharmacokinet; 2001; 40(10):723-51. PubMed ID: 11707060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
    Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
    Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of infliximab with thiopurines significantly reduces white cell and neutrophil counts in inflammatory bowel disease patients.
    Parihar V; Maceneaney O; Maguire S; Garry C; O'Sullivan M; Kennedy M; Safaya K; Smyth C; Farrell R
    Ir J Med Sci; 2017 May; 186(2):329-332. PubMed ID: 27241033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.